CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 651865-651983 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"The study began with a 1-week, placebo lead-in period, followed by a 1-week blinded treatment period (Day 1 to Day 7).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T97653","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T97653","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T186","span":{"begin":0,"end":118},"obj":"Sentence"}],"attributes":[{"subj":"T186","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93bbec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#d5ec93"}]}]}}